Insiders · Profile

Shafer Bradford J

EVP, Gen. Counsel, Secretary at Theravance Biopharma · Sr VP, Gen. Counsel, Secretary at Innoviva. Filing since 1 Aug 2007. CIK 0001302448

Company
Date
Role
Action
Shares
Amount
Of holding
27 Aug 2018
EVP, Gen. Counsel, Secretary
Sold, plan not stated
7,119
$197.28K
7.8%
8 Aug 2018
EVP, Gen. Counsel, Secretary
Sold, plan not stated
25,355
$706.18K
20.5%
7 Aug 2018
EVP, Gen. Counsel, Secretary
Sold, plan not stated
5,945
$168.39K
4.6%
8 Jun 2018
EVP, Gen. Counsel, Secretary
Sold, plan not stated
3,900
$92.26K
2.9%
6 Jun 2018
EVP, Gen. Counsel, Secretary
Sold, plan not stated
10,140
$244.27K
7.1%
6 Sep 2017
EVP, Gen. Counsel, Secretary
Sold, plan not stated
14,670
$451.35K
9.8%
3 Mar 2017
EVP, Gen. Counsel, Secretary
Sold, plan not stated
26,829
$854.77K
14.2%
22 Aug 2016
EVP, Gen. Counsel, Secretary
Sold, plan not stated
37,078
$1.01M
15.9%
19 Aug 2016
EVP, Gen. Counsel, Secretary
Sold, plan not stated
4,870
$137.04K
2.0%
18 Aug 2016
EVP, Gen. Counsel, Secretary
Sold, plan not stated
7,174
$204.82K
2.9%
12 Aug 2014
Sr VP, Gen. Counsel, Secretary
Sold, plan not stated
1,048
$23.37K
0.2%
11 Aug 2014
Sr VP, Gen. Counsel, Secretary
Sold, plan not stated
27,108
$599.63K
5.7%
3 Mar 2014
Sr VP, Gen. Counsel, Secretary
Sold, plan not stated
65,806
$2.42M
16.8%
7 Jun 2013
Sr VP, Gen. Counsel, Secretary
Sold, plan not stated
31,038
$1.09M
9.3%
28 Nov 2011
Sr VP, Gen. Counsel, Secretary
Sold, plan not stated
20,000
$420.00K
5.4%
11 Mar 2011
Sr VP, Gen. Counsel, Secretary
Sold, plan not stated
20,238
$460.62K
5.5%
11 Mar 2011
Sr VP, Gen. Counsel, Secretary
Sold, plan not stated
6,451
$146.76K
100%
30 Jul 2008
Sr VP, Gen. Counsel, Secretary
Sold, plan not stated
34,676
$553.69K
15.2%
31 Oct 2007
Sr VP, Gen. Counsel, Secretary
Sold, plan not stated
25,000
$625.00K
10.1%
1 Aug 2007
Sr VP, Gen. Counsel, Secretary
Sold, plan not stated
25,000
$649.58K
9.2%
20 decisions on file.